Page last updated: 2024-08-24

xemilofiban and simvastatin

xemilofiban has been researched along with simvastatin in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Morris, DC	1
Ferguson, JJ	1

Other Studies

2 other study(ies) available for xemilofiban and simvastatin

Article	Year
Results from late-breaking clinical trials sessions at ACCIS '99 and ACC '99. American College of Cardiology. Journal of the American College of Cardiology, 1999, Volume: 34, Issue:1 Topics: Abciximab; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Anticholesteremic Agents; Anticoagulants; Benzamidines; Coronary Angiography; Coronary Artery Bypass; Coronary Disease; Humans; Immunoglobulin Fab Fragments; Myocardial Ischemia; Myocardial Revascularization; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Simvastatin; Stents; Thrombolytic Therapy; Time Factors; Tissue Plasminogen Activator; Treatment Outcome	1999
Meeting highlights. Highlights of the 48th scientific sessions of the American College of Cardiology. Circulation, 1999, Aug-10, Volume: 100, Issue:6 Topics: Abciximab; Alanine; Angioplasty, Balloon, Coronary; Angiotensin-Converting Enzyme Inhibitors; Antibodies, Monoclonal; Aspirin; Benzamidines; Biphenyl Compounds; Cardiology; Cardiovascular Agents; Clinical Trials as Topic; Clopidogrel; Combined Modality Therapy; Coronary Disease; Dalteparin; Defibrillators, Implantable; Double-Blind Method; Enalapril; Endothelial Growth Factors; Fatty Acids, Omega-3; Guanidines; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunoglobulin Fab Fragments; Laser Therapy; Lymphokines; Metoprolol; Multicenter Studies as Topic; Myocardial Revascularization; Platelet Aggregation Inhibitors; Pyrrolidines; Randomized Controlled Trials as Topic; Simvastatin; Sodium-Hydrogen Exchangers; Stents; Sulfones; Thrombolytic Therapy; Ticlopidine; Tissue Plasminogen Activator; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors; Vitamin E	1999

Article

Year

Results from late-breaking clinical trials sessions at ACCIS '99 and ACC '99. American College of Cardiology.

Journal of the American College of Cardiology, 1999, Volume: 34, Issue:1

Topics: Abciximab; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Anticholesteremic Agents; Anticoagulants; Benzamidines; Coronary Angiography; Coronary Artery Bypass; Coronary Disease; Humans; Immunoglobulin Fab Fragments; Myocardial Ischemia; Myocardial Revascularization; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Simvastatin; Stents; Thrombolytic Therapy; Time Factors; Tissue Plasminogen Activator; Treatment Outcome

1999

Meeting highlights. Highlights of the 48th scientific sessions of the American College of Cardiology.

Circulation, 1999, Aug-10, Volume: 100, Issue:6

Topics: Abciximab; Alanine; Angioplasty, Balloon, Coronary; Angiotensin-Converting Enzyme Inhibitors; Antibodies, Monoclonal; Aspirin; Benzamidines; Biphenyl Compounds; Cardiology; Cardiovascular Agents; Clinical Trials as Topic; Clopidogrel; Combined Modality Therapy; Coronary Disease; Dalteparin; Defibrillators, Implantable; Double-Blind Method; Enalapril; Endothelial Growth Factors; Fatty Acids, Omega-3; Guanidines; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunoglobulin Fab Fragments; Laser Therapy; Lymphokines; Metoprolol; Multicenter Studies as Topic; Myocardial Revascularization; Platelet Aggregation Inhibitors; Pyrrolidines; Randomized Controlled Trials as Topic; Simvastatin; Sodium-Hydrogen Exchangers; Stents; Sulfones; Thrombolytic Therapy; Ticlopidine; Tissue Plasminogen Activator; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors; Vitamin E

1999